Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants

Clinical trial NCT07692685 · COMPLETED

Trial details

NCT number: NCT07692685
Sponsor: Neurodawn Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction Pharmacokinetic Profiles Safty

Start date: 2026-05-07
Primary completion: 2026-06-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.